3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
5
Thoracic
4
Tumor-Agnostic
2
Lymphoid
2
Dermatologic
2
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Uveal Melanoma
1
Skin Neoplasms
1
Sezary Syndrome
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
pembrolizumab
65
Nivolumab
58
Ipilimumab
32
Cyclophosphamide
22
Specimen Handling
16
Magnetic Resonance Spectroscopy
15
Biopsy
15
relatlimab
13
cemiplimab
13
fludarabine
12
Opdualag
12
binimetinib
10
Blood Specimen Collection
10
aldesleukin
9
Radiosurgery
9
encorafenib
8
Interleukin-2
8
atezolizumab
7
Immunotherapy
7
tebentafusp
6
mogamulizumab
6
fludarabine phosphate
6
Temozolomide
6
Surgical Procedures, Operative
6
Paclitaxel
6
Immunoglobulin G
6
CTLA-4 Antigen
6
Radiotherapy
5
Disulfides
5
Bevacizumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Hematologic Tests
×
Dermatologic
×
Clear all
NCT04424719
2025-09-03
SALOME
Institut Curie
Phase NA
Recruiting
700 enrolled
NCT04904146
2025-03-10
BIO-MUSE
Lund University Hospital
Recruiting
120 enrolled